NCT02870673

Brief Summary

In clinical practice, carpal tunnel syndrome (CTS) is the common disease of peripheral neuropathy and usually happened to female, mid-age population, overweight persons, and those who overused their hands for work or production. Some research claimed this might be correlated to anatomical characteristics such as the longer anteroposterior diameter or smaller cross section area of the wrist. Preliminary symptoms often start with sensory domain (pain, tingling, paresthesia and especially night awakening due to symptoms mentioned above) and then progress to motor domain (thenar muscle atrophy and clumsiness) if left untreated. Depending on the severity, patient's willingness and convenience, there are many options for CTS. For those whose symptoms are mild to moderate, conservative therapies are usually the first choice, including physiotherapies, local injection and night splints. Local steroid is proven to be effective to relieve the symptoms of CTS shortly up to 3 months. However, the effects will decline gradually and repetitive injections is suggestive. The patients with severe symptoms which comprise thenar muscle atrophy will be advised to receive decompression surgery.the surgery can alleviate the illness with high success rate up to 70%. Unfortunately, there are still patients who will relapse or undergo side effects, for example, finger weakness. In recent years, acupuncture researches focused on CTS intervention have been outgrowing and promising. Whereas, there are still lack of evidence which stands for the therapeutic effects comparing with local steroid injection. This limits the built-up of suspect mechanism of acupuncture intervention for CTS. This is a preliminary, randomized and single-blinded study which started since 2016 and last for a year. The investigators utilize ultrasound to guide the depth of needle penetration which prevents unnecessarily tissues injury such as artery or dry needle injury. This procedure also guarantees the needles lie directly on the upper surface of the median nerve. One group will receive electrical stimulation and another won't. The investigators use electromyography, cross-section area of median nerve, visual analog scale, Boston Carpal Tunnel Syndrome Questionnaire, six-item scale, The disabilities of the arm, shoulder and hand score and Jamar grip dynamometer as outcome measurements. The results gathered from two experimental groups will be compared with the data from the control group whose participants only receiving local steroid injection once in the first week. The participants are all above 18 years old and complain of illness for a least 3 months without any surgery or local injection for a least 1 year. The investigators set up strict exclusive criteria and sample size estimation is 70.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2016

Shorter than P25 for phase_2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 17, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

August 19, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

August 8, 2016

Last Update Submit

August 18, 2016

Conditions

Keywords

acupunctureelectrical stimulationcarpal tunnel syndrome

Outcome Measures

Primary Outcomes (10)

  • pain assessed on visual analog scale

    24 weeks

  • Boston Carpal Tunnel Syndrome Questionaire

    24 weeks

  • The 6-item CTS symptoms scale

    24 weeks

  • cross sectional area(CSA) of the median nerve

    CSA of the median nerve below the distal wrist crease which is measured by the ultrasound(transverse view )

    24 weeks

  • hand grip power

    Jamar Hand grip Dynamometer as the measuring tool

    24 weeks

  • The Disabilities of the Arm, Shoulder and Hand (DASH) Score

    24 weeks

  • compound muscle action potential(CMAP)

    The CMAP is a summated voltage response from the individual muscle fibre action potentials and measured in millivolts (mV).

    24 weeks

  • Wrist-palm sensory nerve conduction velocity(Wrist-palm SNCV)

    Wrist-palm SNCV (m/s) = distance between stimulation site 1 and site 2 (mm)/\[latency wrist- latency palm(ms)\].

    24 weeks

  • motor nerve conduction velocity(MNCV)

    MNCV (m/s) = distance between stimulation site 1 and site 2 (mm)/\[latency site 2 - latency site 1 (ms)\].

    24 weeks

  • sensory nerve action potential(SNAP)

    The sensory nerve action potential (SNAP) is obtained by electrically stimulating sensory fibres and recording the nerve action potential at a point further along that nerve.

    24 weeks

Study Arms (3)

Injection of Shincort 0.5 ml and Xylocaine 0.5ml mixture

ACTIVE COMPARATOR

In the first week of recruitment, this group will receive the local injection around the distal wrist crease with mixture of Shincort Inj(10mg/ml) 0.5 ml and xylocaine(20mg/ml) 0.5 ml only one time. The ultrasound-guided procedure is performed by the orthopedic physician.

Drug: SHINCORTDrug: XYLOCAINE

sham electroacupuncture

EXPERIMENTAL

In this group, the participants receive acupuncture treatment and only 2 minutes electrical stimulation. Each needle insertion depth and position are confirmed by the ultrasound. The procedure makes sure that needle pin is directly placed on the median nerve and prevent nerve penetration. Then the electrical stimulator is connected to the needles as cathode and anode and is turned on to the intensity which can induce thenar muscle contraction or reach the upper limit of the participant. After 2 minutes, the stimulator will turn off spontaneously and the participant will not be informed. The whole course will cost 20 minutes after needles are pulled out. Every participant is asked to receive 1 treatment per week in the consecutive 3 months(total 12 times).

Device: sham electroacupuncture

electroacupuncture

EXPERIMENTAL

In this group, the participants receive acupuncture treatment and 20 minutes electrical stimulation. Each needle insertion depth and position are confirmed by the ultrasound. The procedure makes sure that needle pin is directly placed on the median nerve and prevent nerve penetration. Then the electrical stimulator is connected to the needles as cathode and anode and is turned on to the intensity which can induce thenar muscle contraction or reach the upper limit of the participant. The whole course will cost 20 minutes after needles are pulled out. Every participant is asked to receive 1 treatment per week in the consecutive 3 months(total 12 times).

Device: electroacupuncture

Interventions

triamcinolone Acetonide (10mg/ml) 0.5 ml

Also known as: triamcinolone Acetonide
Injection of Shincort 0.5 ml and Xylocaine 0.5ml mixture

xylocaine(20mg/ml) 0.5 ml

Also known as: XYLOCAINE IV INJECTION
Injection of Shincort 0.5 ml and Xylocaine 0.5ml mixture

1.5 inches 32 gauze stainless steel needles Transcutaneous electrical nerve stimulation machine (MODEL-05B(6))

sham electroacupuncture

1.5 inches 32 gauze stainless steel needles Transcutaneous electrical nerve stimulation machine (MODEL-05B(6))

electroacupuncture

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants are must above 20 years old,
  • All participants are willing to join and can be cooperated with all the interviews and examinations.
  • The symptoms are compatible with carpal tunnel syndrome, including numbness, pain, paresthesia, tingling, burning sensation over a least 2 fingers and hand motor limitation which are dominated by median nerve.These symptoms have to sustain for more than 3 months and be diagnosed by electromyography, physical examination and physicians.
  • Those who underwent local injection including glucose, steroid or anaphylaxis will be recruited if the treatments finished more than a year.

You may not qualify if:

  • symptoms due to radiculopathy (When the patient also complains of symptoms radiating to the elbow or neck movement pain, the orthopedic doctor will make the definite diagnosis. )
  • Those who underwent decompression surgery.
  • CTS due to traumatic injury (confirmed by image)
  • Those who underwent local injection within a year.
  • CTS due to rheumatoid arthritis
  • CTS due to cancer
  • CTS due to peripheral artery occlusive disease
  • Those who have past history of psychosis.
  • Pregnancy(every woman will be confirmed by urine pregnancy test)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

Triamcinolone AcetonideLidocaineElectroacupuncture

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

TriamcinolonePregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCombined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Central Study Contacts

You-Jen Tang, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 8, 2016

First Posted

August 17, 2016

Study Start

August 1, 2016

Primary Completion

August 1, 2017

Study Completion

September 1, 2017

Last Updated

August 19, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share